Current status and recent progress of nanomaterials in transcatheter arterial chemoembolization therapy for hepatocellular carcinoma

doi:10.5306/wjco.v16.i4.104435

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

(112)

(105)

(0)

(11)

(2457)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Apr 24, 2025; 16(4): 104435
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.104435

Full Size Figure Download Figure

Figure 2 Nanomaterials loaded with chemotherapeutic drugs use their targeting properties to enter into the tumour cells. They cleave and release the chemotherapeutic drugs to reach the nucleus, thus killing the tumour cells.

Citation: Sun J, Li HL, Zhou WJ, Ma ZX, Huang XP, Li C. Current status and recent progress of nanomaterials in transcatheter arterial chemoembolization therapy for hepatocellular carcinoma. World J Clin Oncol 2025; 16(4): 104435
URL: https://www.wjgnet.com/2218-4333/full/v16/i4/104435.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i4.104435

Sun J, Li HL, Zhou WJ, Ma ZX, Huang XP, Li C. Current status and recent progress of nanomaterials in transcatheter arterial chemoembolization therapy for hepatocellular carcinoma. World J Clin Oncol 2025; 16(4): 104435 [PMID: 40290691 DOI: 10.5306/wjco.v16.i4.104435]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.